Bosch Healthcare Solutions GmbH
Stories about Staphylococcus aureus
- Language:
- Media:
- Period:
- Period:Total
- more
ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
Lausanne, Switzerland (ots) - - International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics - The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly ...
moreMicreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance
Zug, Switzerland (ots/PRNewswire) - In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of XZ.700, a novel antibacterial enzyme, in ...
moreMicreos appoints Joost Goderie as CFO and member of the Board of Directors
The Hague, The Netherlands (ots/PRNewswire) - Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos's growth and deliver its targeted antibacterial technology to the world. He will be responsible for ...
moreMicreos appoints Matt Regan as CEO of its Pharmaceutical business
The Hague, Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a separate company as per January 2022 to directly access the capital markets. This will help to fund pipeline development to progress its highly ...
moreMicreos secures EUR32 million for its endolysin-based platform as sustainable alternative to antibiotics
The Hague, The Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos announced it has secured another EUR32 million in funding to further develop its endolysin platform technology, based on targeted killing of only unwanted bacteria. This funding round will help Micreos accelerate its clinical ...
moreHARTMANN launches Mission: Infection Prevention - how prevention is contagious
moreTechnische Universität München
From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35822/ High resolution images: https://mediatum.ub.tum.de/1524870 NEWS RELEASE From cancer medication ...
moreTechnische Universität München
Salt could be a key factor in allergic immune reactions like atopic dermatitis
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22731 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35257/ Pictures: https://mediatum.ub.tum.de/1475815 NEWS RELEASE Salt could be a key factor in allergic immune reactions Atopic dermatitis: elevated ...
more